A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
מצבים רפואיים
Metastatic Uveal Melanoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
HonorHealth Research Insisute, Scottsdale, Arizona, United States
Contact: Study coordinator (Justin Moser, MD)UC San Diego Moores Cancer Center, La Jolla, California, United States
Contact: Study coordinator (Gregory Daniels, MD)The Angeles Clinic and Research Institute, Los Angeles, California, United States
Contact: Study coordinator (Inderjit Mehmi, MD)University of California Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (Bartosz Chmielowski, MD)Stanford Cancer Institute, Palo Alto, California, United States
Contact: Study coordinator (Allison Betof Warner, MD)University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora, Colorado, United States
Contact: Study coordinator (Sapna Pradyuman Patel, MD)The Melanoma & Skin Cancer Institute, Englewood, Colorado, United States
Contact: Study coordinator (Ryan Weight, DO, MS)Georgetown University Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Suthee Rapisuwon, MD)Mayo Clinic - Jacksonville FL, Jacksonville, Florida, United States
Contact: Study coordinator (Roxana S. Dronca, MD)Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Contact: Study coordinator (Leonel Fernando Hernandez Aya, MD)Emory Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Study coordinator (Michael Lowe, MD)Northwestern Memorial Hospital, Chicago, Illinois, United States
Contact: Study coordinator (Sunandana Chandra, MD, MS)University of Chicago Medical Center, Chicago, Illinois, United States
Contact: Study coordinator (Daniel Olson, MD)University of Iowa, Iowa City, Iowa, United States
Contact: Study coordinator (Asad Javed, MD)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Kamaneh Montazeri, MD)Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Arkadiusz Z. Dudek, MD)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Alexander Shoushtari, MD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Study coordinator (April Salama, MD)The Ohio State University, Columbus, Ohio, United States
Contact: Study coordinator (Richard Wu, MD, PhD)Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Marlana Orloff, MD)UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Diwakar Davar, MD)The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee, United States
Contact: Study coordinator (Arnel M. Pallera, MD)University of Tennessee Medical Center, Knoxville, Tennessee, United States
Contact: Study coordinator (Timothy Panella, MD)Sarah Cannon Research Institute, Nashville, Tennessee, United States
Contact: Study coordinator (Meredith Ann McKean, MD, MPH)Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic), Nashville, Tennessee, United States
Contact: Study coordinator (Douglas B. Johnson, MD)UT Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Sanjay Chandrasekaran, MD)The University Of Texas Md Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Alexandra Ikeguchi, MD)Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Study coordinator (Natalie Miller, MD, PhD)University Of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
Contact: Study coordinator (Vincent Ma, MD)Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia
Contact: Study coordinator (Georgina Long, MD)Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Study coordinator (Damien Kee, MD)The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, Merseyside, United Kingdom
Contact: Study coordinator (Joseph Sacco)The Royal Marsden NHS Foundation Trust, London, United Kingdom
Contact: Study coordinator (James Larkin)
מובילי המחקר
Rahul Marpadga, MD MPH
Study Director
Replimune, Inc.